TARGET2
TARGET2[edit | edit source]
.jpg)
TARGET2 (Trans-European Automated Real-time Gross Settlement Express Transfer System 2) is a real-time gross settlement (RTGS) system owned and operated by the Eurosystem. It is used for the settlement of large-value payments in euros and is a critical component of the European financial system.
Overview[edit | edit source]
TARGET2 is the second generation of the TARGET system, which was launched in 1999 to facilitate the integration of the European Union's financial markets. TARGET2 was introduced in November 2007, replacing the original TARGET system, to provide enhanced services and efficiency.
The system is designed to process payments in real-time, ensuring that transactions are settled immediately and irrevocably. This is crucial for maintaining the stability and efficiency of the financial markets within the Eurozone.
Functionality[edit | edit source]
TARGET2 offers a range of services to its participants, including:
- Real-time processing: Payments are settled in real-time, reducing the risk of settlement delays.
- Liquidity management: Participants can manage their liquidity efficiently, with tools to monitor and control their cash positions.
- Cross-border payments: TARGET2 facilitates cross-border payments within the Eurozone, supporting the integration of European financial markets.
Participants[edit | edit source]
The system is used by a wide range of financial institutions, including central banks, commercial banks, and other financial entities. Participation in TARGET2 is mandatory for all central banks in the Eurozone, while commercial banks can choose to participate directly or indirectly through a correspondent bank.
Importance[edit | edit source]
TARGET2 plays a vital role in the functioning of the Eurozone's financial system. It ensures the smooth operation of monetary policy by providing a reliable platform for the settlement of large-value payments. Additionally, it supports the integration of European financial markets by facilitating cross-border transactions.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
